We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Critique |

Use of Gene Expression Profiles in Cells of Peripheral Blood to Identify New Molecular Markers of Acute Pancreatitis—Invited Critique

Nita Ahuja, MD
Arch Surg. 2008;143(3):233-234. doi:10.1001/archsurg.2007.74.
Text Size: A A A
Published online


Will the next generation of surgeons be ordering a gene expression profile with the admission laboratory tests of the patient with pancreatitis? This article by Bluth et al makes this scenario a distinct possibility.

Gene expression profiling using microarrays has emerged as a powerful tool to profile the expression of thousands of genes within the human genome as illustrated by the recent Food and Drug Administration approval of the MammaPrint (Agendia, Louwesweg, Amsterdam) assay for breast cancer prognosis.1 In expression profiling, RNA is isolated from tissues and hybridized to complementary probes for specific genes that are fixed in a grid in small microscopic spots, typically on a glass slide, and the intensity of the hybridization probes correlates with expression compared with controls. This allows a comprehensive look at the expression profile for any disease state or allows comparison of different subsets to develop predictive signatures. Previous investigators have used expression profiling to characterize acute pancreatitis using fresh tissues.2,3 In their article, Bluth et al now describe a noninvasive modality, using an easily accessible source, PBMCs, to perform expression profiling for the characterization of severe pancreatitis in a rat model. The investigators are to be applauded for doing this successfully.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections